Electrical Therapeutic Systems Patents (Class 607/2)
  • Patent number: 9968775
    Abstract: Tether apparatus may be used to replace an implanted lead extension with a replacement lead extension without tunneling or the use of tunneling tools.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: May 15, 2018
    Assignee: MEDTRONIC, INC.
    Inventors: Peter Appenrodt, Daniel Schmitz, Paul van Venrooij
  • Patent number: 9968329
    Abstract: A processing device detects a medical device and sends an audio wake-up signal to the medical device, wherein the audio wake-up signal causes the medical device to transition from a low power state to a higher power state. The processing device receives a diagnostic audio signal from the medical device after sending the audio wake-up signal. The processing device processes the diagnostic audio signal to determine medical information of a patient, the medical information comprising at least one of heart beat information or breathing information of the patient. The processing device performs at least one of storing the medical information or transmitting the medical information to a remote computing device.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: May 15, 2018
    Assignee: CliniCloud Inc.
    Inventors: Hon Weng Chong, Lain Cai Cai, An Lin, Robert James Skillington
  • Patent number: 9962542
    Abstract: Systems and methods for deep brain electrode placement and deep brain stimulation (DBS) for treatment of conditions such as obesity are disclosed. In one example approach, during placement of a deep brain stimulating electrode in a target region of the brain of a patient, a temperature of brown adipose tissue (BAT) may be monitored, e.g., via a supraclavicular temperature sensor implanted in the patient, and used to identify an optimal location of electrode stimulation which causes an increase in BAT temperature. Additionally, BAT temperature measurements may be used to provide regulated closed-loop control to increase efficiency of DBS while reducing energy consumption of the pulse generator. Further, core temperature measurements may be obtained from the electrode in the brain and used to adjust DBS.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: May 8, 2018
    Assignee: Oregon Health & Science University
    Inventors: Kim Burchiel, Christopher J. Madden, Shaun F. Morrison
  • Patent number: 9962544
    Abstract: An electrode connector assembly for use in transcutaneous electrical stimulation includes a flexible web extending in a plane and first, second, third and fourth electrode connectors carried by the web and spaced from each other about the web in the plane. The electrode connector assembly further includes an electrical connector and first, second, third and fourth conductors electrically coupling the respective first, second, third and fourth electrode connectors to the electrical connector.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: May 8, 2018
    Assignee: GI Therapies Pty Ltd
    Inventors: Bridget Rae Southwell, David Fisher, Rod Wiebenga, Lisa Tjernberg
  • Patent number: 9962543
    Abstract: In some embodiments, a paddle lead is implanted within a patient such that the electrodes are positioned within the cervical or thoracic spinal levels. An electrode combination on a first row of electrodes can be determined that is effective for a first pain location with minimal effects on other regions of the body. The first pain location can be addressed by stimulating a first dorsal column fiber due to the relatively fine electrical field resolution achievable by the multiple columns. Then, another electrode combination on a second row of electrodes can be determined for a second pain location with minimal effects on other regions. The second pain location could be addressed by stimulating a second dorsal column fiber. After the determination of the appropriate electrodes for stimulation, the patient's IPG can be programmed to deliver pulses using the first and second rows according to the determined electrode combinations.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: May 8, 2018
    Assignee: Advanced Neuromodulation Systems, Inc.
    Inventors: Claudio A. Feler, John H. Erickson
  • Patent number: 9962546
    Abstract: A CFS system includes self-adhesive, disposable pads. Each pad is combined with a sealed, cleanable battery/controller pod and then placed on the body where needed. The battery/controller pod preferably has wireless capability, such as Bluetooth® capability. The patient can download an application to a smartphone or similar mobile device to control the pods.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: May 8, 2018
    Assignee: Meagan Medical, Inc.
    Inventors: William J. Carroll, Mark Edward Schoening, Patrick Allen Scranton, William Richard Huseby
  • Patent number: 9962475
    Abstract: Disclosed herein are heart pumps that can include a catheter body and an impeller coupled with a distal end of the catheter body. The impeller can include a tip that is resealable or that includes a resealable member. The heart pump can also include a diffuser disposed between the distal end of the catheter body and the impeller, wherein the diffuser includes a flow directing surface.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: May 8, 2018
    Assignees: TC1 LLC, THE PENN STATE RESEARCH FOUNDATION
    Inventors: Robert L. Campbell, Jeremy J. Koncoski, Thomas M. Mallison, Mark W. McBride, Daniel Metrey, Eric C. Myer, Kevin J. Powell, Adam Roslund, Daniel A. Walters, William James Repka, Phyllis Yuen
  • Patent number: 9956409
    Abstract: Spinal cord stimulation (SCS) system having a recharging system with self alignment, a system for mapping current fields using a completely wireless system, multiple independent electrode stimulation outsource, and control through software on Smartphone/mobile device and tablet hardware during trial and permanent implants. SCS system can include multiple electrodes, multiple, independently programmable, stimulation channels within an implantable pulse generator (IPG) providing concurrent, but unique stimulation fields. SCS system can include a replenishable power source, rechargeable using transcutaneous power transmissions between antenna coil pairs. An external charger unit, having its own rechargeable battery, can charge the IPG replenishable power source. A real-time clock can provide an auto-run schedule for daily stimulation. A bi-directional telemetry link informs the patient or clinician the status of the system, including the state of charge of the IPG battery.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: May 1, 2018
    Assignee: Globus Medical, Inc.
    Inventors: Saif Khalil, Raghavendra Angara, Miles Curtis, Christopher Biele, Daniel Fellmeth
  • Patent number: 9956421
    Abstract: Designs and methods of construction for an implantable medical device employ an internal support structure. The single-piece support structure holds various electronic components such as a communication coil and a circuit board, and further is affixed to a battery, thus providing a subassembly that is mechanically robust. The support structure further provides electrical isolation between these and other components. A method of construction allows for the subassembly to be adhered to a case of the implantable medical device at the support structure, and possibly also at the battery, without electrically shorting the battery to the case.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: May 1, 2018
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Navin N. Bunyan, Robert R. Tong, Jeffery Van Funderburk
  • Patent number: 9956393
    Abstract: The disclosed wearable device modulates a patient's gastric emptying time and/or gastric retention time. The wearable device includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 dermatome to a T12 dermatome or meridian of the patient, a C5 to a T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: May 1, 2018
    Assignee: Elira, Inc.
    Inventors: Raul E. Perez, Peter I. Hong, Steven Diianni, Luis Jose Malave, Brad Stengel
  • Patent number: 9959471
    Abstract: A system for monitoring a patient in a patient area having one or more detection zones, the system comprising one or more cameras, a user interface, and a computing system configured to receive a chronological series of frames from the one or more cameras, identify liquid candidates by comparing a current frame with a plurality of previous frames of the chronological series, determine locations of the liquid candidates, identify thermal signatures of the liquid candidates, determine types of liquids of the liquid candidates based on the locations and thermal signatures of the liquid candidates, and generate an alert with the user interface corresponding to the determined types of liquids.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: May 1, 2018
    Assignee: CareView Communications, Inc.
    Inventors: Steven Gail Johnson, Derek del Carpio, Kenneth W. Chapman
  • Patent number: 9943683
    Abstract: A patch for a therapeutic electrical stimulation device includes a shoe connected to the first side of the patch, the shoe including a body extending in a longitudinal direction from a first end to a second end, and having first and second surfaces, the first end of the shoe defining at least two ports, and the first surface of the shoe defining a connection member. The patch also includes at least one conductor positioned in the ports of the first end of the shoe. The shoe is configured for sliding insertion into a receptacle defined by a controller so that the conductor is connected to the controller to deliver electrical current from the controller, through the conductor, and to the electrodes, and the connection member is at least partially captured by a detent defined by the controller in the receptacle to retain the shoe within the receptacle.
    Type: Grant
    Filed: August 1, 2017
    Date of Patent: April 17, 2018
    Assignee: DJO, LLC
    Inventors: Thomas Jerome Bachinski, Richard Paul Shindley, Dennis Lutz
  • Patent number: 9925379
    Abstract: A computer implemented method and system is provided for managing neural stimulation therapy. The method comprises under control of one or more processors configured with program instructions. The method delivers a series of candidate stimulation waveforms having varied stimulation intensities to at least one electrode located proximate to nervous tissue of interest. A parameter defines the candidate stimulation waveforms is changed to vary the stimulation intensity. The method identifies a first candidate stimulation waveform that induces a paresthesia-abatement effect, while continuing to induce a select analgesic effect. The method further identifies a second candidate stimulation waveform that does not induce the select analgesic effect. The method sets a stimulation therapy based on the first and second candidate stimulation waveforms.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: March 27, 2018
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Alexander Kent, Richard Williamson
  • Patent number: 9913979
    Abstract: Multiple designs, systems, methods and processes for control using electrical signals recorded from clinically paralyzed muscles and nerves are presented. The discomplete neural prosthesis system and method for clinically paralyzed humans utilizes a controller. The controller is adapted to receive a volitional electrical signal generated by the human that is manifest below the lesion that causes the clinical paralysis. The controller uses at least the volitional electrical signal to generate a control signal that is output back to a plant to change the state of the plant, which in one aspect is one or more of the user's paralyzed muscles to achieve a functional result or to devices in the environment around the user that are adapted to receive commands from the controller.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: March 13, 2018
    Assignee: Case Western Reserve University
    Inventors: Christa Wheeler Moss, Paul Hunter Peckham
  • Patent number: 9907954
    Abstract: Devices, systems, and methods for accessing the internal and external tissues of the heart are disclosed. At least some of the embodiments disclosed herein provide access to the external surface of the heart through the pericardial space for localized delivery of substances to the heart tissue. In addition, various disclosed embodiments provide access to the internal surface of the heart for aspiration and delivery of substances to a targeted region without disturbing or interfering with nearby structures or surfaces.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: March 6, 2018
    Assignee: CVDevices, LLC
    Inventors: Ghassan S. Kassab, Jose A. Navia, Sr.
  • Patent number: 9901710
    Abstract: Steering engagement catheter devices, systems, and methods of using the same for accessing a tissue, including internal and external tissues of a heart, are disclosed. In at least one embodiment, a steering engagement catheter is provided, comprising an elongated tube having a proximal end, a distal end, and a first wall positioned circumferentially along a length of the elongated tube, the elongated tube configured such that a delivery catheter is capable of at least partial insertion into the elongated tube, at least one steering wire having a proximal end and a distal end, the distal end of the at least one steering wire coupled to the first wall of the elongated tube at or near the distal end of the elongated tube, and a controller operably coupled to the at least one steering wire at or near the proximal end of the at least one steering wire.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: February 27, 2018
    Assignee: CVDevices, LLC
    Inventors: Ghassan S. Kassab, Jose A. Navia, Sr.
  • Patent number: 9895541
    Abstract: A method for controlling a position of a patient's tongue includes attaching at least one electrode to the patient's Hypoglossal nerve and applying an electric signal through the electrode to at least one targeted motor efferent located within the Hypoglossal nerve to stimulate at least one muscle of the tongue. Methods may also include the use of more than one contact to target more than one motor efferent and stimulating more than one muscle. The stimulation load to maintain the position of the tongue may be shared by each muscle. The position of the patient's tongue may be controlled in order to prevent obstructive sleep apnea.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: February 20, 2018
    Assignee: IMTHERA MEDICAL, INC.
    Inventors: Paul M. Meadows, Marcelo G. Lima, Faisal N. Zaidi
  • Patent number: 9895539
    Abstract: Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: February 20, 2018
    Assignee: Nevro Corp.
    Inventors: Gary Heit, Bradford Evan Gliner
  • Patent number: 9875340
    Abstract: Systems and methods disclosed herein provide efficacious pain management therapies based on delivery of physical medicine(s) via computer-implemented systems. Patient information comprising patient pain symptoms, patient physiological measurements, patient demographics, and other information is received at a pain therapy device. The patient information is compared with pain analytics data compiled on a plurality of individuals to determine a personalized pain management therapy. The personalized pain management therapy is applied via a combination of thermoceuticals, electroceuticals, ultrasound, and several other forms of physical medicine. Sensors coupled to the pain therapy device measure changes in physiological data resulting from the pain management therapy. The personalized pain management therapy can be adjusted based on the changes in the physiological data and/or patient feedback.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: January 23, 2018
    Assignee: ITRACE BIOMEDICAL INC.
    Inventor: Krishnamohan Sharma
  • Patent number: 9872999
    Abstract: A cardiac pacing system comprising one or more leadless cardiac pacemakers configured for implantation in electrical contact with a cardiac chamber and configured to perform cardiac pacing functions in combination with a co-implanted implantable cardioverter-defibrillator (ICD). The leadless cardiac pacemaker comprises at least two leadless electrodes configured for delivering cardiac pacing pulses, sensing evoked and/or natural cardiac electrical signals, and bidirectionally communicating with the co-implanted ICD.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: January 23, 2018
    Assignee: Pacesetter, Inc.
    Inventor: Peter M. Jacobson
  • Patent number: 9861810
    Abstract: Thermal drawing processes can be used to make multifunctional, high-resolution neural probes for neural recording and stimulation. An exemplary neural probe may include one or more conductive fibers or microelectrodes coated with two or more layers of insulating material, at least one of which is partially etched to expose a tip at the neural probe's distal end. The conductive fibers conduct electrical signals (e.g., neural spikes or electrical stimulation) between the tip and the neural probe's proximal end. Optional optical and fluidic waveguides may guide light and fluid, respectively, between the tip and the proximal end. A neural probe may be flexible enough for long-term (chronic) implantation in neural tissue (e.g., the brain) without excessive tissue damage, even during movement of the brain in the skull. The probe may be made from biocompatible materials, such as insulating and conductive polymers, that have negligible (insignificant) interaction with the surrounding tissue.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: January 9, 2018
    Assignee: Massachusetts Institute of Technology
    Inventors: Polina Olegovna Anikeeva, Xiaoting Jia, Chi Lu, Andres Canales, Ulrich Paul Froriep, Christina Myra Tringides, Yoel Fink
  • Patent number: 9855439
    Abstract: High frequency cardiac arrhythmias and fibrillations are terminated by electric field pacing pulses having an order of magnitude less energy than a conventional cardioversion or defibrillation energy. The frequency and number of the pulses are selected based on a frequency analysis of a present high frequency cardiac arrhythmia or fibrillation. The energy of the pulses is selected from 1/400 to ½ of the conventional defibrillation energy, and the amplitude of the electric field pacing pulses are selected such as to activate a multitude of effective pacing sites in the heart tissue per each pacing electrode. The number and locations of the effective pacing sites in the heart tissue are regulated by the amplitude of the electric field pacing pulses, and by an orientation of the electric field of the pulses.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: January 2, 2018
    Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Valentin Krinski, Eberhard Bodenschatz, Stefan Luther
  • Patent number: 9855435
    Abstract: The present disclosure provides leadless pacemaker systems and methods. A leadless pacemaker includes a battery subassembly, a feedthrough subassembly, and an electronics subassembly coupled between the battery subassembly and the feedthrough subassembly, the electronics subassembly including an electronics package, and a housing configured to provide a hermetic seal and comprising a first retaining feature and a second retaining feature configured to secure the electronics package within the housing.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: January 2, 2018
    Assignee: PACESETTER, INC.
    Inventors: Kavous Sahabi, Arees Garabed
  • Patent number: 9855431
    Abstract: Various device embodiments may comprise an implantable medical device for implantation in a body and for applying neural stimulation to a neural target in the body. The device may comprise a neural stimulation electrode configured for use in stimulating the neural target, a neural stimulator configured to deliver neural stimulation through the electrode to the neural target, a sensor configured to sense a physiological response to stimulation of motor fibers at the neural target, and a controller operatively connected to the neural stimulator to control the neural stimulation and operatively connected to the sensor to receive a signal indicative of the physiological response. The controller may be configured to detect a potential neural injury and perform an action in response to the detected potential neural injury.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: January 2, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David J. Ternes, Jason J. Hamann, Stephen Ruble
  • Patent number: 9839577
    Abstract: An auricular peripheral nerve field stimulator system includes an electrical stimulation device for generating electrical stimulation signals and a plurality of therapy electrodes each electrically coupled to the electrical stimulation device and each including a plurality of needles for percutaneous insertion into an auricle of a human ear near at least one neural vascular bundle located therein. In some embodiments, at least one reference electrode electrically is coupled to the electrical stimulation device and includes at least one needle for percutaneous insertion into or adjacent the auricle to provide a ground reference for the electrical stimulation device. The generated electrical stimulation signals are, in any case, delivered by the percutaneously inserted needles to stimulate an auricular peripheral nerve field within the auricle.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: December 12, 2017
    Assignee: Innovative Health Solutions, Inc.
    Inventors: Christopher R. Brown, Gary M. Peterson
  • Patent number: 9839466
    Abstract: Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: December 12, 2017
    Assignee: Covidien LP
    Inventors: David S. Utley, John de Csepel
  • Patent number: 9833617
    Abstract: An insulated electrode system for delivering a plurality of tumor treating electromagnetic fields including an array of electrode elements for proximate location on a body of a patient. Each electrode element of the array having an insulation layer. Each electrode element being independently electrically accessible and configured to be dynamically assigned to emanate an electromagnetic field relative to at least one other of said electrode elements.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: December 5, 2017
    Assignee: Loyalty Based Innovations, LLC
    Inventors: Peter F. Travers, Ken Watkins, Timothy VanderMey
  • Patent number: 9827040
    Abstract: Methods and apparatus are provided for intravascularly-induced neuromodulation using a pulsed electric field, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation, etc., in target neural fibers. In some embodiments, the intravascular PEF system comprises a catheter having a pair of bipolar electrodes for delivering the PEF, with a first electrode positioned on a first side of an impedance-altering element and a second electrode positioned on an opposing side of the impedance-altering element. A length of the electrodes, as well as a separation distance between the first and second electrodes, may be specified such that, with the impedance-altering element deployed in a manner that locally increases impedance within a patient's vessel, e.g.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: November 28, 2017
    Assignee: Medtronic Adrian Luxembourg S.a.r.l.
    Inventors: Denise Zarins, Nicolas Zadno, Benjamin J. Clark, Erik Thai
  • Patent number: 9827422
    Abstract: An example of a system may include an electrode arrangement and a neuromodulation device configured to use electrodes in the electrode arrangement to generate a neuromodulation field. The neuromodulation device may include a neuromodulation generator, a neuromodulation control circuit and a storage. The storage may include a stochastically-modulated neuromodulation parameter set and the stochastically-modulated neuromodulation parameter set may include at least one stochastically-modulated parameter. The controller may be configured to control the neuromodulation generator using the stochastically-modulation parameter set to generate the neuromodulation field.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: November 28, 2017
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Changfang Zhu
  • Patent number: 9802058
    Abstract: A transcranial magnetic stimulation coil which is location-specific for medial brain regions or lateral brain regions is designed with multiple spaced apart stimulating elements having current flow in a first direction, and multiple return elements having current flow in a second direction which is opposite the first direction. The multiple stimulating elements are distributed around a central axis of the coil.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: October 31, 2017
    Assignee: BRAINSWAY, LTD.
    Inventors: Abraham Zangen, Yiftach Roth
  • Patent number: 9802049
    Abstract: Apparatus and methods for stimulating tissue employing local current imbalance to facilitate more effective stimulation regimens.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: October 31, 2017
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventor: Kerry Bradley
  • Patent number: 9802042
    Abstract: A method for providing electrical stimulation to a user as a user performs a set of tasks during a time window, the method comprising: providing an electrical stimulation treatment, characterized by a stimulation parameter and a set of portions, to a brain region of the user in association with the time window; for each task of the set of tasks: receiving a signal stream characterizing a neurological state of the user; from the signal stream, identifying a neurological signature characterizing the neurological state associated with the task; and modulating the electrical stimulation treatment provided to the brain region of the user based upon the neurological signature, wherein modulating comprises delivering a portion of the set of portions of the electrical stimulation treatment to the brain region of the user, while maintaining an aggregate amount of the stimulation parameter of the treatment provided during the time window below a maximum limit.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: October 31, 2017
    Assignee: Halo Neuro, Inc.
    Inventors: Brett Wingeier, Daniel S. Chao, Lee Von Kraus, Amol Sarva, Sophia Sanchez
  • Patent number: 9795795
    Abstract: Some embodiments relate to a device for generating stimulation signals, comprising: a stimulation delivery circuit; a first component to monitor charge delivered in at least one charge pulse via the stimulation delivery circuit; and a second component to ensure delivered charge substantially corresponds to charge of a charge pulse intended to be delivered by the stimulation delivery circuit. In some embodiments, the device may further comprise a charge setting circuit responsive to a charge pulse setting signal, such as a constant current of fixed pulse width, to set the charge of the charge pulse intended to be delivered.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: October 24, 2017
    Assignee: The Bionics Institute of Australia
    Inventors: Peter Misha Seligman, Hugh Joseph McDermott
  • Patent number: 9795450
    Abstract: Apparatus is provided for ablating cardiac tissue of a subject. The apparatus comprises an inflatable element, configured to be transthoracically placed within a pericardial region of the subject and a reflection-facilitation element, configured to deliver a fluid to the pericardial region, such that a portion of the fluid is disposed within the inflatable element, and another portion of the fluid is disposed outside of the inflatable element and inside the pericardial region. The apparatus additionally comprises at least one ultrasound transducer, configured to be transcatheterally placed in a heart chamber of the subject, and to apply ultrasound energy such that at least a portion of the applied energy is reflected by the fluid. Other embodiments are also described.
    Type: Grant
    Filed: January 2, 2015
    Date of Patent: October 24, 2017
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Liat Tsoref, Yossi Gross
  • Patent number: 9782597
    Abstract: A lead extension at least one lead extension body; terminals disposed along one end portion of the lead extension body(ies); a lead extension connector disposed along another end portion of the lead extension body(ies); and conductors electrically coupling the connector contacts in the lead extension connector to the terminals. The lead extension connector can include lead channels with non-straight paths to facilitate retention of leads. Alternatively, the lead extension connector can include one or more stretchable boots to each receive a lead when stretched and to grip the lead when relaxed. Alternatively, the lead extension connector can have two connector bodies with a pin channel and pin, respectively. When the pin is inserted into the pin channel, the pin compresses a portion of the connector body against the lead to retain the lead within the connector.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: October 10, 2017
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Christopher Shanahan, Geoffrey Abellana Villarta
  • Patent number: 9775671
    Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: October 3, 2017
    Assignee: LaZure Scientific, Inc.
    Inventor: Larry Azure
  • Patent number: 9757302
    Abstract: Systems configured to apply pressure to a foot and electrically stimulate muscles to contract in order to increase circulation and facilitate removal of metabolic waste, and related methods, are disclosed. One exemplary embodiment comprises an actuator that repeatedly compresses the bottom of a foot and an electrical muscle stimulator that repeatedly sends electrical pulses to a muscle to facilitate a muscle contraction. The system may also include a compression garment, such as a compression sock to be worn while undergoing both the repeated compression cycles and the repeated electrical pulses. The system may also include an item of footwear, wherein the actuator portion is partially or completely contained within the item of footwear. Additionally and/or alternatively, the electrical muscle stimulator may be partially or completely contained within the item of footwear.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: September 12, 2017
    Assignee: AVEX, LLC
    Inventor: Matthew J. Mayer
  • Patent number: 9757554
    Abstract: In some embodiments, an apparatus includes a substantially rigid base and a flexible substrate. The substantially rigid base has a first protrusion and a second protrusion, and is configured to be coupled to an electronic device. The flexible substrate has a first surface and a second surface, and includes an electrical circuit configured to electronically couple the electronic device to at least one of an electrode a battery, or an antenna. The flexible substrate is coupled to the base such that a first portion of the second surface is in contact with the first protrusion. A second portion of the second surface is non-parallel to the first portion.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: September 12, 2017
    Assignee: Bioness Inc.
    Inventors: Amit Dar, Shai Feldman, Arkady Glukhovsky, Shmuel Springer, Einan Regev
  • Patent number: 9757192
    Abstract: A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: September 12, 2017
    Assignee: Medtronic Ardian Luxembourg S.a.r.l.
    Inventors: Howard R. Levin, Mark Gelfand
  • Patent number: 9743983
    Abstract: A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: August 29, 2017
    Assignee: Medtronic Ardian Luxembourg S.a.r.l.
    Inventors: Howard R. Levin, Mark Gelfand
  • Patent number: 9737725
    Abstract: Apparatuses, systems and methods of treating a vertebrate organism via application of signals in a manner that enhances biological function. The signals applied can be produced by an electronic circuit, and can comprise magnetic fields emitted via one or more coil emitter devices.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: August 22, 2017
    Inventor: Elizabeth A. Rauscher
  • Patent number: 9737705
    Abstract: A patch for a therapeutic electrical stimulation device includes a shoe connected to the first side of the patch, the shoe including a body extending in a longitudinal direction from a first end to a second end, and having first and second surfaces, the first end of the shoe defining at least two ports, and the first surface of the shoe defining a connection member. The patch also includes at least one conductor positioned in the ports of the first end of the shoe. The shoe is configured for sliding insertion into a receptacle defined by a controller so that the conductor is connected to the controller to deliver electrical current from the controller, through the conductor, and to the electrodes, and the connection member is at least partially captured by a detent defined by the controller in the receptacle to retain the shoe within the receptacle.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: August 22, 2017
    Assignee: DJO, LLC
    Inventors: Thomas Jerome Bachinski, Richard Paul Shindley, Dennis Lutz
  • Patent number: 9737702
    Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: August 22, 2017
    Assignee: Oculeve, Inc.
    Inventors: Douglas Michael Ackermann, James Donald Loudin, John Wardle, Jarren Armond Baldwin, Daniel N. Hamilton, Janusz Kuzma
  • Patent number: 9731127
    Abstract: Cutaneous and subcutaneous TNS embodiments are disclosed for addressing autonomic nervous system imbalances. A cutaneous electrode assembly is applied to a patient's forehead, and a current is pulsed through the electrode assembly to stimulate the supraorbital and supratrochlear nerves on the patient to increase activity for the patient's parasympathetic nervous system. Pulsing the current increases the power spectral density for the patient's heart rate variability in a 0.1 to 0.15 Hz frequency band.
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: August 15, 2017
    Assignee: NeuroSigma, Inc.
    Inventors: Colin Kealey, Leon Ekchian
  • Patent number: 9731125
    Abstract: A device and method are provided for altering body mass composition in a human subject by applying galvanic vestibular stimulation (GVS) using electrodes placed in electrical contact with the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems. The current source include a feedback loop for measuring a resistance across the subject's scalp and adjusting a voltage output to maintain a constant current across the subject's scalp. GVS may be applied for a predetermined period of time at regular intervals.
    Type: Grant
    Filed: February 28, 2014
    Date of Patent: August 15, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Paul Duncan McGeoch, Vilayanur S. Ramachandran
  • Patent number: 9731140
    Abstract: Some computer-assisted methods include: presenting configuration options to a user of the implanted stimulator device, the configuration options comprising stimulation parameters for the implanted stimulator; receiving a user specification of the configuration options in response to the presented configuration options; receiving user feedback when the user specified configuration options are implemented at the implanted stimulator device, the user feedback comprising a quantitative index of pain resulting from implementing the user specified configuration options on the implanted stimulator device; building a user profile for the user based on the user specified configuration options and the user feedback, the user profile including the user specified configuration options as well as the corresponding quantitative index of pain; and selecting at least one configuration option based on the user profile when the configuration options are subsequently presented to the user for a later treatment.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: August 15, 2017
    Assignee: Micron Devices LLC
    Inventors: Laura Tyler Perryman, Chad David Andresen
  • Patent number: 9724511
    Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: August 8, 2017
    Assignee: Medtronic, Inc.
    Inventors: Xuan K. Wei, Eric H. Bonde, Keith A. Miesel, Mark S. Lent, Gregory F. Molnar
  • Patent number: 9717435
    Abstract: A portable medical device having an intravenous line flow sensor integrated into a cable. The portable medical device may be a defibrillator having an ECG or electrode cable couple to ECG or electrode leads. The flow sensor may be integrated into the ECG or electrode cable. The portable medical device uses the flow sensor to capture and store information about fluids delivered to a patient being treated with the portable medical device. The information may include total volume provided, flow rate, and the like. The information may then be used to evaluate the treatment provided to the patient.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: August 1, 2017
    Assignee: Physio-Control, Inc.
    Inventors: Robert G. Walker, Barry D. Curtin
  • Patent number: 9707396
    Abstract: Techniques, devices, and systems may include screening effective therapies using cortical evoked potentials. In one example, a system may be configured to receive a first sensed cortical evoked potential of a patient that occurred in response to an induced sensation at an anatomical region different from a brain region of the patient and receive a second sensed cortical evoked potential that occurred in response to electrical stimulation delivered to one or more nerves associated with the anatomical region. The electrical stimulation may be at least partially defined by a set of therapy parameter values. The system may also compare a first value of a characteristic of the first sensed cortical evoked potential to a second value of the characteristic of the second sensed cortical evoked potential and determine, based on the comparison, efficacy of a therapy configured to treat a condition associated with the anatomical region.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: July 18, 2017
    Assignee: Medtronic, Inc.
    Inventors: Xin Su, Dwight E. Nelson
  • Patent number: 9707395
    Abstract: An algorithm programmed into the control circuitry of a rechargeable-battery Implantable Medical Device (IMD) is disclosed that can adjust the charging current (Ibat) provided to the rechargeable battery over time (e.g., the life of the IMD) in accordance with one or more of the parameters having an effect on rechargeable battery capacity, such as number of charging cycles, charging current, discharge depth, load current, and battery calendar age. The algorithm consults such parameters as stored over the history of the operation of the IMD in a parameter log, and in conjunction with a battery capacity database reflective of the effect of these parameters on battery capacity, estimates a change in the capacity of the battery, and adjust the charging current in one or both of trickle and active charging paths to slow the loss of battery capacity and extend the life of the IMD.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: July 18, 2017
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Goran N. Marnfeldt, Rafael Carbunaru, Jordi Parramon